CompletedPhase 2NCT02343133
Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
Studying Acute radiation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Neumedicines Inc.
- Principal Investigator
- Nicholas Siebers, MD, OTCovance Clinical Research
- Intervention
- HemaMax(biological)
- Enrollment
- 200 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2015 – 2016
Study locations (4)
- Covance Clinical Research Unit, Daytona Beach, Florida, United States
- Covance Clinical Research Unit, Evansville, Indiana, United States
- Covance Clinical Research Unit, Dallas, Texas, United States
- Covance Clinical Research Unit, Madison, Wisconsin, United States
Collaborators
Department of Health and Human Services
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02343133 on ClinicalTrials.govOther trials for Acute radiation syndrome
Additional recruiting or active studies for the same condition.